(1)
Dobre, E.-G.; Voi, M.; Orlandi, E.; Martinis , C. de; Constantin, C.; Zipeto, D.; Valenti, M.-T.; Neagu, M. Investigating RUNX2 KO in B16 Melanoma Cells As a Potential Strategy to Enhance in Vivo Tumor Response to Therapeutic Approaches. SEE J Immunol 2025, 8, 065.